REVEAL GENOMICS and Ona Therapeutics today announced a strategic collaboration aimed at accelerating the clinical development ...

Reveal Genomics and Ona Therapeutics have formed a strategic partnership to expedite the clinical development of the antibody-drug conjugate (ADC), ONA-255, tailored to improve the cancer treatment's ...

Spanish biotech Reveal Genomics has formed a strategic partnership with oncology firm Ona Therapeutics to support the clinical development of ONA-255, a novel antibody-drug conjugate designed to ...

All the Latest Game Footage and Images from Ona: A Mystical Art Experience Travel across the world in an interactive and meditative journey to resolve the quest of our humanity. Advertisement All ...

BARCELONA, Spain, Feb. 19, 2025 /PRNewswire/ -- Ona Therapeutics ("Ona"), a global biotech company pioneering first-in-class antibody-drug conjugates (ADCs), today announced key leadership ...

The issuer is solely responsible for the content of this announcement.